What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism

@HajBrum @PatientJournal @HEU_UoB Yeah, we worked with a patient-centered advisory board throughout and gained additional insights from a patient-only Delphi panel we published in @PatientJournal https://t.co/HrSO0hSvUW

@arpartington

Our @PCORI-funded advisory board helped us design a Delphi panel of #HCV patients to identify “What matters most to patients in #HCV treatment decisions” published by @PatientJournal (6/12) https://t.co/SR3867KHDE

Our recent case example: We utilized a patient stakeholder advisory board & then enrolled a 30-patient Delphi panel to determine “What matters most to Hep C patients” when it comes to treatment (#CEA research planning phase!) (12/14) @PatientJournal

You can read this article for free here: https://t.co/yb7odLt1nU

RT @UMBpatricia: Altruistic desires are among factors impacting patients’ decisions, according to author @joeymattingly @umsop & colleagues…

RT @IHVmaryland: Check out this article on What Matters Most for Treatment Decisions in Hepatitis C by researchers at IHV, @umsop and @NHCo…

Altruistic desires are among factors impacting patients’ decisions, according to author @joeymattingly @umsop & colleagues Perfetto @NHCouncil, Kottilil @IHVmaryland, & Slejko & Mullins @umsop

RT @IHVmaryland: Check out this article on What Matters Most for Treatment Decisions in Hepatitis C by researchers at IHV, @umsop and @NHCo…

Check out this article on What Matters Most for Treatment Decisions in Hepatitis C by researchers at IHV, @umsop and @NHCouncil published in @PatientJournal: https://t.co/ZFBBkKIoUH

RT @joeymattingly: New study alert: "What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism" @Patient…

@MedicinesNZ What matters most for treatment decisions in Hepatitis C https://t.co/FuImBC4kOp

@joeymattingly https://t.co/FuImBC4kOp

RT @PECjournal: @joeymattingly @PatientJournal @juliaslejko @liverUSA @PCORI Read for free here https://t.co/FuImBC4kOp

@joeymattingly @PatientJournal @juliaslejko @liverUSA @PCORI Read for free here https://t.co/FuImBC4kOp

RT @joeymattingly: New study alert: "What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism" @Patient…

RT @joeymattingly: New study alert: "What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism" @Patient…

New study alert: "What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism" @PatientJournal @juliaslejko @liverUSA @PCORI #HCV #value (Tweetorial: 1/12) https://t.co/SR3867t6M6